Concepedia

Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction

David E. Mosedale, Duncan J. Smith, Sri W. Aitken, Peter M. Schofield, Stéphanie Clarke, Duncan McNab, Hester Goddard, Catharine R. Galé, C N Martyn, H J Bethell

Atherosclerosis · 2005 · 36 citations · 25 references

DOI

Concepts

References

25

Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

Landin Boring, Jennifa Gosling, Michael D. Cleary et al. · Nature · 1998 · 2K citations

, , +14

Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice

Long Gu, Yoshikatsu Okada, Steven K. Clinton et al. · Molecular Cell · 1998 · 1.6K citations · Full text

, , +12

Monocyte chemoattractant protein-1 in human atheromatous plaques.

N A Nelken, Shaun R. Coughlin, David J. Gordon et al. · Journal of Clinical Investigation · 1991 · 886 citations · Full text

, , +15

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B

Jennifa Gosling, Sarah Slaymaker, Long Gu et al. · Journal of Clinical Investigation · 1999 · 662 citations · Full text

, , +17

Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3

Motoji Kitaura, Toshihiro Nakajima, Toshio Imai et al. · Journal of Biological Chemistry · 1996 · 416 citations · Full text

, , +13